GlassScriptPhysician profile
Jalpen Patel
NPI 1619397643
$7,466.39
in general payments reported to CMS, 2019-2025
27 companies · $1,879 in 2025
The $1,879 reported for 2025 was more than what 89% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,994 · 2020: $430 · 2021: $509 · 2022: $79.95 · 2023: $120 · 2024: $454 · 2025: $1,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303 · Travel and Lodging: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.23 |
| Travel and Lodging | $1,149.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,219.22 | 2019-2023 | Variax, Citrefix, Asnis |
| Paragon 28, INC. | $1,016.70 | 2019-2023 | |
| Trilliant Surgical LLC. | $957.61 | 2019-2025 | Arsenal Sinus Support Plate |
| Medshape, INC. | $596.21 | 2025 | Dynanail |
| Reel Surgical, INC. | $419.34 | 2020 | |
| Arthrex, INC. | $378.23 | 2024-2025 | |
| Medical Device Business Services, INC. | $339.97 | 2019 | |
| Sanara Medtech INC. | $306.13 | 2024 | Celleraterx, Texagen |
| Smith+Nephew, INC. | $177.27 | 2019-2021 | |
| Stability Biologics, LLC | $163.07 | 2021 | |
| Bard Peripheral Vascular, INC. | $156.85 | 2021 | |
| Orthofix Medical, INC. | $126.69 | 2025 | Truelok |
| In2bones USA, LLC | $120.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $115.55 | 2020-2025 | Accufill |
| Organogenesis INC. | $87.92 | 2022-2023 | Puraply |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $57.16 | 2019 | |
| Paratek Pharmaceuticals, INC. | $34.62 | 2025 | Nuzyra |
| Abbott Laboratories | $24.97 | 2023 | Proclaim |
| Axogen | $23.67 | 2021 | |
| Depuy Synthes Sales INC. | $22.91 | 2022 | |
| Crossroads Extremity Systems, LLC | $21.90 | 2019-2021 | |
| Janssen Biotech, INC. | $20.05 | 2021 | |
| Heron Therapeutics, INC. | $19.56 | 2022 | |
| Reprise Biomedical, INC. | $19.05 | 2025 | Miro3d |
| Bioventus LLC | $16.57 | 2025 | Exogen Ultrasound Bone Healing System |
| Embody, INC. | $16.00 | 2021 | |
| Next Science LLC | $9.17 | 2023 | Blastx, Xperience, Surgx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jalpen Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.